Cytokine Release Syndrome in Patients with Covid-19-induced Pneumonia
📧 Sign up to get email alerts when something new happens for Cytokine Release Syndrome in Patients with Covid-19-induced Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia [Phase 3]
Phase 3 trial evaluating canakinumab for cytokine release syndrome in COVID-19–related pneumonia completed; results posted in 2021.